25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HLB Life Science Co. Ltd
Buy, Hold or Sell?

Let's analyze HLB Life Science Co. Ltd together

I guess you are interested in HLB Life Science Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of HLB Life Science Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about HLB Life Science Co. Ltd

I send you an email if I find something interesting about HLB Life Science Co. Ltd.

1. Quick Overview

1.1. Quick analysis of HLB Life Science Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of HLB Life Science Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩3,030.22
Expected worth in 1 year
₩3,855.59
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
₩825.37
Return On Investment
8.0%

For what price can you sell your share?

Current Price per Share
₩10,350.00
Expected price per share
₩7,700 - ₩12,080
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of HLB Life Science Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩10,350.00

2.2. Growth of HLB Life Science Co. Ltd (5 min.)




Is HLB Life Science Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$251.5m$178m$40.3m18.5%

How much money is HLB Life Science Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$8.1m$6.5m406.6%
Net Profit Margin-13.1%-49.7%--

How much money comes from the company's main activities?

2.3. Financial Health of HLB Life Science Co. Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of HLB Life Science Co. Ltd?

Welcome investor! HLB Life Science Co. Ltd's management wants to use your money to grow the business. In return you get a share of HLB Life Science Co. Ltd.

First you should know what it really means to hold a share of HLB Life Science Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of HLB Life Science Co. Ltd is ₩10,350. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HLB Life Science Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HLB Life Science Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩3,030.22. Based on the TTM, the Book Value Change Per Share is ₩206.34 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-99.44 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HLB Life Science Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.850.0%-0.010.0%-0.080.0%-0.080.0%-0.040.0%
Usd Book Value Change Per Share-0.540.0%0.140.0%-0.070.0%-0.120.0%0.050.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.540.0%0.140.0%-0.070.0%-0.120.0%0.050.0%
Usd Price Per Share5.75-8.63-7.79-10.63-8.24-
Price to Earnings Ratio-1.69-8.75-4.24-11.30-258.79-
Price-to-Total Gains Ratio-10.64-30.12-24.77-26.92--21.35-
Price to Book Ratio2.71-4.45-4.54-4.10-8.20-
Price-to-Total Gains Ratio-10.64-30.12-24.77-26.92--21.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.245
Number of shares138
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.14-0.12
Usd Total Gains Per Share0.14-0.12
Gains per Quarter (138 shares)19.93-16.44
Gains per Year (138 shares)79.73-65.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1080700-66-76
201591500-132-142
302392300-197-208
403193100-263-274
503993900-329-340
604784700-395-406
705585500-460-472
806386300-526-538
907187100-592-604
1007977900-658-670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%14.018.08.035.0%15.018.013.032.6%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%21.019.00.052.5%25.021.00.054.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.011.00.045.0%21.019.00.052.5%25.021.00.054.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of HLB Life Science Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---772.543206.343-474%-99.435-87%-170.216-78%69.174-1217%
Book Value Per Share--3030.2152766.585+10%2452.768+24%3975.053-24%2700.596+12%
Current Ratio--2.1091.946+8%5.216-60%7.829-73%4.553-54%
Debt To Asset Ratio--0.2720.374-27%0.415-35%0.246+10%0.411-34%
Debt To Equity Ratio--0.3740.627-40%0.713-48%0.3750%1.085-66%
Dividend Per Share----0%-0%-0%-0%
Eps---1217.908-8.674-99%-114.113-91%-114.178-91%-63.630-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.800+25%
Market Cap484817805000.000-101%974863205340.0001381074143132.076-29%1153800121856.160-16%1159524674298.087-16%775926210709.702+26%
Net Profit Margin---6.125-0.131-98%-0.497-92%-0.419-93%-0.211-97%
Operating Margin----0%-0.0350%-0.1120%-0.0660%
Operating Ratio--2.0512.258-9%1.887+9%1.487+38%1.454+41%
Pb Ratio3.416+21%2.7134.455-39%4.544-40%4.097-34%8.198-67%
Pe Ratio-2.125-26%-1.6878.747-119%4.244-140%11.302-115%258.793-101%
Price Per Share10350.000+21%8220.00012322.505-33%11122.505-26%15181.006-46%11778.254-30%
Price To Free Cash Flow Ratio----27.4570%2673.434-100%513.885-100%248.183-100%
Price To Total Gains Ratio-13.397-26%-10.64030.121-135%24.775-143%26.920-140%-21.353+101%
Quick Ratio---0.807-100%5.810-100%11.096-100%6.139-100%
Return On Assets---0.293-0.022-93%-0.030-90%-0.029-90%-0.012-96%
Return On Equity---0.402-0.028-93%-0.053-87%-0.038-91%-0.012-97%
Total Gains Per Share---772.543206.343-474%-99.435-87%-170.216-78%69.174-1217%
Usd Book Value--251561051.700218460379.967+15%178062243.336+41%199101502.180+26%122932025.306+105%
Usd Book Value Change Per Share---0.5410.144-474%-0.070-87%-0.119-78%0.048-1217%
Usd Book Value Per Share--2.1211.937+10%1.717+24%2.783-24%1.890+12%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.853-0.006-99%-0.080-91%-0.080-91%-0.045-95%
Usd Free Cash Flow----5605922.6110%-7967762.9380%-4910809.2550%-2393081.1550%
Usd Market Cap339372463.500-101%682404243.738966751900.192-29%807660085.299-16%811667272.009-16%543148347.497+26%
Usd Price Per Share7.245+21%5.7548.626-33%7.786-26%10.627-46%8.245-30%
Usd Profit---101107710.900-1610789.835-98%-8159496.816-92%-5625418.797-94%-2848404.464-97%
Usd Revenue--16506670.60016252260.187+2%21062913.828-22%15738981.836+5%14110487.841+17%
Usd Total Gains Per Share---0.5410.144-474%-0.070-87%-0.119-78%0.048-1217%
 EOD+2 -5MRQTTM+11 -15YOY+9 -185Y+7 -2010Y+14 -14

3.3 Fundamental Score

Let's check the fundamental score of HLB Life Science Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.125
Price to Book Ratio (EOD)Between0-13.416
Net Profit Margin (MRQ)Greater than0-6.125
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.109
Debt to Asset Ratio (MRQ)Less than10.272
Debt to Equity Ratio (MRQ)Less than10.374
Return on Equity (MRQ)Greater than0.15-0.402
Return on Assets (MRQ)Greater than0.05-0.293
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of HLB Life Science Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.779
Ma 20Greater thanMa 509,131.500
Ma 50Greater thanMa 1009,769.200
Ma 100Greater thanMa 20010,387.300
OpenGreater thanClose10,600.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About HLB Life Science Co. Ltd

HLB Life Science Co., Ltd. engages in the wholesaling and distribution of pharmaceuticals in South Korea and internationally. It also develops Rivoceranib, a small-molecule tyrosine kinase inhibitor for the treatment of various cancers, including gastric cancer, colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer, esophageal cancer, thyroid cancer, mesothelioma, and neuroendocrine tumors; Seclidemstat, a novel epigenetic oral small molecule for target therapy to normalize gene expression and suppress tumor growth in various solid tumors, such as lung, breast, and prostate cancer; and Tegavivint, inhibitor of the Wnt/ß-catenin for the treatment of desmoid tumors, acute myeloid leukemia, osteosarcoma, and a range of solid tumor types. In addition, the company develops LifeLiver, an extracorporeal bioartificial liver system; HepaStem, a heterologous human adult liver-derived progenitor cell therapy; and HLBLS-200, a biocompatible polysaccharide-based powders that forms adhesive hemostasis upon contact with blood. Further, it is involved in the waste heat recovery, cogeneration power generation, facility installation, solar energy, photovoltaic power generation, bioenergy, geothermal energy, waste energy, wind power, and fuel cell businesses. The company also undertakes energy efficiency projects; and builds heating/heating system improvement projects. The company was formerly known as Energy Solutions Co., Ltd. and changed its name to HLB Life Science Co.,Ltd. in December 2015. HLB Life Science Co.,Ltd. was founded in 1998 and is headquartered in Hwaseong, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 18:09:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit HLB Life Science Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of -612.5% means that ₩-6.13 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HLB Life Science Co. Ltd:

  • The MRQ is -612.5%. The company is making a huge loss. -2
  • The TTM is -13.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-612.5%TTM-13.1%-599.4%
TTM-13.1%YOY-49.7%+36.6%
TTM-13.1%5Y-41.9%+28.8%
5Y-41.9%10Y-21.1%-20.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-612.5%9.8%-622.3%
TTM-13.1%9.5%-22.6%
YOY-49.7%9.9%-59.6%
5Y-41.9%12.9%-54.8%
10Y-21.1%12.6%-33.7%
4.3.1.2. Return on Assets

Shows how efficient HLB Life Science Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • -29.3% Return on Assets means that HLB Life Science Co. Ltd generated ₩-0.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HLB Life Science Co. Ltd:

  • The MRQ is -29.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.3%TTM-2.2%-27.1%
TTM-2.2%YOY-3.0%+0.8%
TTM-2.2%5Y-2.9%+0.8%
5Y-2.9%10Y-1.2%-1.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.3%3.6%-32.9%
TTM-2.2%3.5%-5.7%
YOY-3.0%5.3%-8.3%
5Y-2.9%5.9%-8.8%
10Y-1.2%4.9%-6.1%
4.3.1.3. Return on Equity

Shows how efficient HLB Life Science Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • -40.2% Return on Equity means HLB Life Science Co. Ltd generated ₩-0.40 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HLB Life Science Co. Ltd:

  • The MRQ is -40.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.2%TTM-2.8%-37.5%
TTM-2.8%YOY-5.3%+2.5%
TTM-2.8%5Y-3.8%+1.0%
5Y-3.8%10Y-1.2%-2.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.2%4.6%-44.8%
TTM-2.8%4.6%-7.4%
YOY-5.3%8.2%-13.5%
5Y-3.8%9.1%-12.9%
10Y-1.2%10.3%-11.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of HLB Life Science Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient HLB Life Science Co. Ltd is operating .

  • Measures how much profit HLB Life Science Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HLB Life Science Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.5%+3.5%
TTM-5Y-11.2%+11.2%
5Y-11.2%10Y-6.6%-4.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY-3.5%12.4%-15.9%
5Y-11.2%8.6%-19.8%
10Y-6.6%12.1%-18.7%
4.3.2.2. Operating Ratio

Measures how efficient HLB Life Science Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 2.05 means that the operating costs are ₩2.05 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of HLB Life Science Co. Ltd:

  • The MRQ is 2.051. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.258. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.051TTM2.258-0.208
TTM2.258YOY1.887+0.371
TTM2.2585Y1.487+0.771
5Y1.48710Y1.454+0.033
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0511.225+0.826
TTM2.2581.220+1.038
YOY1.8871.311+0.576
5Y1.4871.249+0.238
10Y1.4541.240+0.214
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of HLB Life Science Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if HLB Life Science Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 2.11 means the company has ₩2.11 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of HLB Life Science Co. Ltd:

  • The MRQ is 2.109. The company is able to pay all its short-term debts. +1
  • The TTM is 1.946. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.109TTM1.946+0.163
TTM1.946YOY5.216-3.270
TTM1.9465Y7.829-5.883
5Y7.82910Y4.553+3.276
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1092.213-0.104
TTM1.9462.234-0.288
YOY5.2162.028+3.188
5Y7.8292.199+5.630
10Y4.5531.995+2.558
4.4.3.2. Quick Ratio

Measures if HLB Life Science Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HLB Life Science Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.807-0.807
TTM0.807YOY5.810-5.004
TTM0.8075Y11.096-10.289
5Y11.09610Y6.139+4.957
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM0.8070.973-0.166
YOY5.8101.515+4.295
5Y11.0961.591+9.505
10Y6.1391.399+4.740
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of HLB Life Science Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of HLB Life Science Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare HLB Life Science Co. Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.27 means that HLB Life Science Co. Ltd assets are financed with 27.2% credit (debt) and the remaining percentage (100% - 27.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HLB Life Science Co. Ltd:

  • The MRQ is 0.272. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.374. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.272TTM0.374-0.102
TTM0.374YOY0.415-0.041
TTM0.3745Y0.246+0.128
5Y0.24610Y0.411-0.165
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2720.345-0.073
TTM0.3740.339+0.035
YOY0.4150.333+0.082
5Y0.2460.315-0.069
10Y0.4110.339+0.072
4.5.4.2. Debt to Equity Ratio

Measures if HLB Life Science Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 37.4% means that company has ₩0.37 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HLB Life Science Co. Ltd:

  • The MRQ is 0.374. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.627. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.374TTM0.627-0.253
TTM0.627YOY0.713-0.086
TTM0.6275Y0.375+0.252
5Y0.37510Y1.085-0.710
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3740.547-0.173
TTM0.6270.547+0.080
YOY0.7130.499+0.214
5Y0.3750.476-0.101
10Y1.0850.548+0.537
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings HLB Life Science Co. Ltd generates.

  • Above 15 is considered overpriced but always compare HLB Life Science Co. Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of -1.69 means the investor is paying ₩-1.69 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HLB Life Science Co. Ltd:

  • The EOD is -2.125. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.687. Based on the earnings, the company is expensive. -2
  • The TTM is 8.747. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-2.125MRQ-1.687-0.437
MRQ-1.687TTM8.747-10.434
TTM8.747YOY4.244+4.503
TTM8.7475Y11.302-2.556
5Y11.30210Y258.793-247.490
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-2.12527.863-29.988
MRQ-1.68729.844-31.531
TTM8.74727.532-18.785
YOY4.24423.102-18.858
5Y11.30227.577-16.275
10Y258.79329.248+229.545
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HLB Life Science Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27.457+27.457
TTM-27.457YOY2,673.434-2,700.892
TTM-27.4575Y513.885-541.342
5Y513.88510Y248.183+265.702
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-27.45729.447-56.904
YOY2,673.43426.360+2,647.074
5Y513.88531.734+482.151
10Y248.18334.357+213.826
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of HLB Life Science Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 2.71 means the investor is paying ₩2.71 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of HLB Life Science Co. Ltd:

  • The EOD is 3.416. Based on the equity, the company is fair priced.
  • The MRQ is 2.713. Based on the equity, the company is underpriced. +1
  • The TTM is 4.455. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.416MRQ2.713+0.703
MRQ2.713TTM4.455-1.742
TTM4.455YOY4.544-0.089
TTM4.4555Y4.097+0.358
5Y4.09710Y8.198-4.102
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD3.4164.659-1.243
MRQ2.7133.381-0.668
TTM4.4553.209+1.246
YOY4.5442.597+1.947
5Y4.0973.278+0.819
10Y8.1984.179+4.019
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets493,651,488
Total Liabilities134,278,557
Total Stockholder Equity358,927,891
 As reported
Total Liabilities 134,278,557
Total Stockholder Equity+ 358,927,891
Total Assets = 493,651,488

Assets

Total Assets493,651,488
Total Current Assets143,156,480
Long-term Assets350,495,008
Total Current Assets
Total Current Assets  (as reported)143,156,480
Total Current Assets  (calculated)0
+/- 143,156,480
Long-term Assets
Long-term Assets  (as reported)350,495,008
Long-term Assets  (calculated)0
+/- 350,495,008

Liabilities & Shareholders' Equity

Total Current Liabilities67,879,630
Long-term Liabilities66,398,927
Total Stockholder Equity358,927,891
Total Current Liabilities
Total Current Liabilities  (as reported)67,879,630
Total Current Liabilities  (calculated)0
+/- 67,879,630
Long-term Liabilities
Long-term Liabilities  (as reported)66,398,927
Long-term Liabilities  (calculated)0
+/- 66,398,927
Total Stockholder Equity
Total Stockholder Equity (as reported)358,927,891
Total Stockholder Equity (calculated)0
+/- 358,927,891
Other
Common Stock Shares Outstanding 118,596
Net Invested Capital 358,927,891
Net Working Capital 75,276,850



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
43,660,996
43,826,813
47,112,052
48,225,407
37,419,884
43,280,002
38,626,453
33,394,395
32,414,222
30,862,286
28,830,841
42,698,934
40,342,232
38,428,639
79,721,720
82,678,312
81,648,520
82,961,101
85,404,841
99,018,088
196,439,370
195,247,529
228,327,950
386,255,479
387,260,388
433,128,162
354,609,771
404,935,130
379,528,734
375,108,333
364,979,127
327,196,942
308,184,050
295,947,670
333,100,695
270,799,569
255,576,197
367,434,498
484,721,182
411,790,371
426,713,922
414,268,092
414,435,179
423,500,448
629,553,669
493,651,488
493,651,488629,553,669423,500,448414,435,179414,268,092426,713,922411,790,371484,721,182367,434,498255,576,197270,799,569333,100,695295,947,670308,184,050327,196,942364,979,127375,108,333379,528,734404,935,130354,609,771433,128,162387,260,388386,255,479228,327,950195,247,529196,439,37099,018,08885,404,84182,961,10181,648,52082,678,31279,721,72038,428,63940,342,23242,698,93428,830,84130,862,28632,414,22233,394,39538,626,45343,280,00237,419,88448,225,40747,112,05243,826,81343,660,996
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,239,835
52,226,397
74,450,909
89,964,940
88,581,401
89,260,468
239,086,216
199,826,267
189,228,774
111,958,074
223,667,024
189,346,911
183,053,673
167,480,133
181,328,966
165,653,215
153,088,959
197,018,164
156,822,300
131,614,062
243,220,819
230,009,089
160,775,696
173,459,361
64,452,111
96,646,547
147,043,191
229,728,204
143,156,480
143,156,480229,728,204147,043,19196,646,54764,452,111173,459,361160,775,696230,009,089243,220,819131,614,062156,822,300197,018,164153,088,959165,653,215181,328,966167,480,133183,053,673189,346,911223,667,024111,958,074189,228,774199,826,267239,086,21689,260,46888,581,40189,964,94074,450,90952,226,39749,239,83500000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
958,072
4,308,043
13,444,638
16,652,223
20,031,068
16,097,954
16,862,217
16,135,043
71,008,892
13,770,182
36,768,620
23,788,522
24,209,431
8,965,434
37,156,899
46,006,208
55,656,489
36,429,012
0
2,375
2,135
1,454
30,978,386
30,373,522
32,033,333
23,582,400
16,768,575
55,569,341
0
055,569,34116,768,57523,582,40032,033,33330,373,52230,978,3861,4542,1352,375036,429,01255,656,48946,006,20837,156,8998,965,43424,209,43123,788,52236,768,62013,770,18271,008,89216,135,04316,862,21716,097,95420,031,06816,652,22313,444,6384,308,043958,07200000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,490,388
3,550,388
5,447,388
19,305,430
23,099,713
31,545,810
177,929,080
137,420,757
75,505,999
47,109,815
0
0
0
129,857,755
120,876,957
106,250,457
85,892,630
145,553,256
108,706,933
87,024,630
90,717,712
138,946,040
97,292,557
122,962,372
11,383,974
49,861,556
62,091,109
105,358,323
0
0105,358,32362,091,10949,861,55611,383,974122,962,37297,292,557138,946,04090,717,71287,024,630108,706,933145,553,25685,892,630106,250,457120,876,957129,857,75500047,109,81575,505,999137,420,757177,929,08031,545,81023,099,71319,305,4305,447,3883,550,3883,490,38800000000000000000
       Net Receivables 
12,326,590
13,215,574
0
10,636,196
0
9,296,862
0
7,907,791
6,106,341
7,579,076
5,939,687
4,064,232
4,181,828
4,467,551
29,467,312
31,757,596
32,848,154
33,214,248
31,987,341
37,920,895
38,133,462
34,480,613
31,837,230
34,175,303
33,064,260
33,291,095
42,024,210
40,155,159
42,549,028
35,654,141
25,432,556
19,348,602
9,330,298
9,131,559
13,083,469
14,156,595
10,347,950
12,285,642
20,374,462
12,942,293
7,668,062
7,961,808
10,162,973
11,464,334
12,975,102
0
012,975,10211,464,33410,162,9737,961,8087,668,06212,942,29320,374,46212,285,64210,347,95014,156,59513,083,4699,131,5599,330,29819,348,60225,432,55635,654,14142,549,02840,155,15942,024,21033,291,09533,064,26034,175,30331,837,23034,480,61338,133,46237,920,89531,987,34133,214,24832,848,15431,757,59629,467,3124,467,5514,181,8284,064,2325,939,6877,579,0766,106,3417,907,79109,296,862010,636,196013,215,57412,326,590
       Other Current Assets 
768,478
2,003,986
14,127,418
19,903,176
21,028,521
2,973,235
9,553,252
1,679,360
3,668,844
2,277,403
2,298,337
1,445,689
2,184,435
1,285,712
3,808,836
2,642,215
5,361,903
11,210,482
11,936,368
568,274
669,983
2,090,419
3,884,104
4,057,283
3,787,863
2,821,596
1,577,701
606,415
1,972,807
1,610,062
26,485,573
1,468,384
11,792,328
1,021,261
13,499,753
654,904
665,605
10,738,110
4,586,063
3,717,989
1,880,044
689,265
1,163,322
1
771,197
0
0771,19711,163,322689,2651,880,0443,717,9894,586,06310,738,110665,605654,90413,499,7531,021,26111,792,3281,468,38426,485,5731,610,0621,972,807606,4151,577,7012,821,5963,787,8634,057,2833,884,1042,090,419669,983568,27411,936,36811,210,4825,361,9032,642,2153,808,8361,285,7122,184,4351,445,6892,298,3372,277,4033,668,8441,679,3609,553,2522,973,23521,028,52119,903,17614,127,4182,003,986768,478
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
251,014,675
253,254,561
349,815,981
317,788,632
276,457,256
399,825,466
350,495,008
350,495,008399,825,466276,457,256317,788,632349,815,981253,254,561251,014,675000000000000000000000000000000000000000
       Property Plant Equipment 
10,487,805
10,665,900
11,049,116
3,078,888
3,055,562
3,628,228
3,646,138
3,538,224
3,554,391
3,485,546
3,436,004
3,377,789
3,382,871
3,334,588
3,619,540
3,585,599
3,474,466
3,237,772
3,289,271
3,283,860
3,707,414
3,488,240
3,522,833
746,814
2,491,894
17,988,035
15,856,071
23,056,350
28,576,354
23,211,961
24,097,359
22,935,212
24,297,910
23,726,344
22,034,145
22,080,765
22,025,731
21,487,944
95,149,742
92,088,796
95,579,712
96,342,104
77,702,072
72,918,303
76,064,719
0
076,064,71972,918,30377,702,07296,342,10495,579,71292,088,79695,149,74221,487,94422,025,73122,080,76522,034,14523,726,34424,297,91022,935,21224,097,35923,211,96128,576,35423,056,35015,856,07117,988,0352,491,894746,8143,522,8333,488,2403,707,4143,283,8603,289,2713,237,7723,474,4663,585,5993,619,5403,334,5883,382,8713,377,7893,436,0043,485,5463,554,3913,538,2243,646,1383,628,2283,055,5623,078,88811,049,11610,665,90010,487,805
       Goodwill 
0
0
0
0
0
4,517,278
4,517,278
1,402,011
1,402,011
1,402,011
1,402,011
0
0
0
1,591,714
586,024
586,025
586,025
586,025
586,025
76,410,465
76,410,465
76,410,465
48,801,442
48,801,442
51,374,321
51,267,526
22,603,377
0
0
22,603,377
1,895,884
1,895,884
1,895,884
1,895,884
0
0
0
38,464,734
21,924,795
0
0
0
1,772,113
1,772,113
0
01,772,1131,772,11300021,924,79538,464,7340001,895,8841,895,8841,895,8841,895,88422,603,3770022,603,37751,267,52651,374,32148,801,44248,801,44276,410,46576,410,46576,410,465586,025586,025586,025586,025586,0241,591,7140001,402,0111,402,0111,402,0111,402,0114,517,2784,517,27800000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,143,415
17,514,637
18,122,777
21,463,714
21,818,852
21,969,465
20,612,754
56,619,360
94,705,473
96,140,951
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000096,140,95194,705,47356,619,36020,612,75421,969,46521,818,85221,463,71418,122,77717,514,63718,143,41500000000000000000
       Intangible Assets 
36,437
47,081
57,047
52,051
47,054
4,702,265
4,685,212
3,135,545
3,037,219
3,466,456
2,865,711
189,986
184,782
178,503
1,944,482
3,426,952
3,387,114
3,233,822
3,197,521
2,105,066
77,916,902
2,552,576
34,849,068
71,870,113
71,858,815
72,014,108
72,056,896
73,749,029
96,853,048
96,716,325
76,217,387
75,439,857
75,537,124
75,431,020
74,853,420
62,809,123
62,775,085
62,744,824
63,758,411
69,506,404
91,154,039
89,703,407
91,510,049
54,028,698
53,923,623
0
053,923,62354,028,69891,510,04989,703,40791,154,03969,506,40463,758,41162,744,82462,775,08562,809,12374,853,42075,431,02075,537,12475,439,85776,217,38796,716,32596,853,04873,749,02972,056,89672,014,10871,858,81571,870,11334,849,0682,552,57677,916,9022,105,0663,197,5213,233,8223,387,1143,426,9521,944,482178,503184,782189,9862,865,7113,466,4563,037,2193,135,5454,685,2124,702,26547,05452,05157,04747,08136,437
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
152,406
260,890
0
0
0
0
0000260,890152,406-1000000000000000000000000000000000000000
> Total Liabilities 
36,407,426
37,789,073
35,248,069
37,190,973
25,440,489
30,948,878
26,135,743
19,953,228
19,638,546
24,404,393
24,717,896
16,803,902
15,668,523
14,825,788
54,885,973
54,993,341
54,720,353
56,176,086
58,798,161
46,191,682
143,358,761
120,756,659
143,990,061
165,016,265
94,861,964
131,719,325
67,200,147
71,112,455
71,099,186
64,120,584
42,256,788
40,015,934
36,483,407
40,964,679
30,784,546
24,610,569
19,939,087
106,042,546
189,315,567
177,065,421
176,859,682
176,754,364
189,518,781
192,287,513
196,710,904
134,278,557
134,278,557196,710,904192,287,513189,518,781176,754,364176,859,682177,065,421189,315,567106,042,54619,939,08724,610,56930,784,54640,964,67936,483,40740,015,93442,256,78864,120,58471,099,18671,112,45567,200,147131,719,32594,861,964165,016,265143,990,061120,756,659143,358,76146,191,68258,798,16156,176,08654,720,35354,993,34154,885,97314,825,78815,668,52316,803,90224,717,89624,404,39319,638,54619,953,22826,135,74330,948,87825,440,48937,190,97335,248,06937,789,07336,407,426
   > Total Current Liabilities 
18,533,568
24,268,984
24,047,920
29,656,975
19,216,277
23,321,118
19,398,303
15,231,731
13,923,220
18,803,178
19,394,821
14,532,922
13,417,241
13,129,699
34,987,925
36,721,095
36,152,441
51,288,814
41,061,058
36,550,926
36,213,299
32,325,284
36,793,749
48,638,695
46,026,084
43,351,188
39,064,927
39,844,715
39,783,648
29,759,679
20,276,035
17,865,344
13,773,007
17,740,547
7,287,395
13,535,842
8,847,736
15,225,325
40,788,518
26,784,511
26,564,026
23,926,772
32,170,897
135,456,990
144,795,739
67,879,630
67,879,630144,795,739135,456,99032,170,89723,926,77226,564,02626,784,51140,788,51815,225,3258,847,73613,535,8427,287,39517,740,54713,773,00717,865,34420,276,03529,759,67939,783,64839,844,71539,064,92743,351,18846,026,08448,638,69536,793,74932,325,28436,213,29936,550,92641,061,05851,288,81436,152,44136,721,09534,987,92513,129,69913,417,24114,532,92219,394,82118,803,17813,923,22015,231,73119,398,30323,321,11819,216,27729,656,97524,047,92024,268,98418,533,568
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,147,905
19,823,321
1,600,000
1,600,000
83,246,931
0
0
0
0
0
700,000
0
0
0
0
0
1,000,000
0
0
0
0
8,670,000
7,920,000
0
0
0
0
0
0
0000007,920,0008,670,00000001,000,00000000700,0000000083,246,9311,600,0001,600,00019,823,32121,147,90500000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,147,905
19,823,321
1,600,000
1,600,000
83,246,931
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,307,200
10,639,150
11,142,200
18,844,000
113,821,148
124,314,514
0
0124,314,514113,821,14818,844,00011,142,20010,639,1508,307,2000000000000000000083,246,9311,600,0001,600,00019,823,32121,147,90500000000000000000
       Accounts payable 
2,248,271
2,541,634
0
6,821,132
3,118,640
5,322,248
0
4,053,279
4,202,810
6,981,894
4,965,260
5,294,703
0
4,109,974
0
27,546,867
0
0
0
29,755,071
28,820,831
26,667,739
0
22,805,433
0
0
0
26,726,167
0
0
0
5,547,953
0
3,788,144
0
10,278,082
6,035,413
9,249,393
11,168,119
9,384,028
7,755,096
6,781,703
6,746,189
5,160,179
6,199,116
0
06,199,1165,160,1796,746,1896,781,7037,755,0969,384,02811,168,1199,249,3936,035,41310,278,08203,788,14405,547,95300026,726,16700022,805,433026,667,73928,820,83129,755,07100027,546,86704,109,97405,294,7034,965,2606,981,8944,202,8104,053,27905,322,2483,118,6406,821,13202,541,6342,248,271
       Other Current Liabilities 
3,891,538
4,862,828
10,245,694
8,939,896
5,885,731
6,572,933
10,754,683
4,135,614
5,429,667
3,934,044
4,973,900
5,793,517
9,170,363
4,086,324
29,390,780
3,645,526
29,035,846
34,473,536
38,381,058
4,115,855
4,672,468
4,037,545
35,173,749
11,840,330
36,819,208
41,134,192
37,493,935
11,254,408
39,499,917
29,513,431
19,834,077
11,355,253
13,299,727
12,267,697
6,595,599
1,871,938
1,678,195
4,826,297
18,022,042
27,660
758,679
1,136,116
1,942,116
1,471
2,241,984
0
02,241,9841,4711,942,1161,136,116758,67927,66018,022,0424,826,2971,678,1951,871,9386,595,59912,267,69713,299,72711,355,25319,834,07729,513,43139,499,91711,254,40837,493,93541,134,19236,819,20811,840,33035,173,7494,037,5454,672,4684,115,85538,381,05834,473,53629,035,8463,645,52629,390,7804,086,3249,170,3635,793,5174,973,9003,934,0445,429,6674,135,61410,754,6836,572,9335,885,7318,939,89610,245,6944,862,8283,891,538
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,939,211
150,295,656
152,827,592
157,347,883
56,830,524
51,915,166
66,398,927
66,398,92751,915,16656,830,524157,347,883152,827,592150,295,656148,939,211000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,142,996
10,575,311
10,639,752
14,348,349
10,876,601
11,013,713
11,285,413
11,859,838
11,934,208
3,952,623
3,878,041
78,558,792
133,306,999
137,021,270
0
0
0
0
0
0
000000137,021,270133,306,99978,558,7923,878,0413,952,62311,934,20811,859,83811,285,41311,013,71310,876,60114,348,34910,639,75210,575,3117,142,99600000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-21,147,905
-19,823,321
-1,600,000
-1,600,000
-83,246,931
0
0
0
0
0
-700,000
0
0
0
0
0
-1,000,000
0
0
0
0
-8,670,000
-4,942,693
2,613,835
1,689,237
1,640,668
1,346,348
1,034,928
0
01,034,9281,346,3481,640,6681,689,2372,613,835-4,942,693-8,670,0000000-1,000,00000000-700,00000000-83,246,931-1,600,000-1,600,000-19,823,321-21,147,90500000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-1
0
0
-1
0
0
00-100-1-1000000000000000000000000000000000000000
> Total Stockholder Equity
7,253,570
6,037,740
11,863,982
11,034,434
11,979,396
12,331,124
12,490,710
13,441,167
12,775,676
6,457,893
4,112,945
25,895,032
24,673,709
23,602,851
24,835,747
27,684,971
26,928,166
26,785,015
26,606,680
52,826,406
51,635,655
73,139,229
83,005,729
219,085,580
290,267,281
299,728,123
287,409,624
333,822,675
308,429,548
310,987,749
322,722,339
287,181,007
271,700,643
254,982,991
302,316,148
246,189,000
235,637,110
261,391,952
295,405,615
234,724,951
248,483,724
237,153,853
224,535,218
230,796,723
432,134,156
358,927,891
358,927,891432,134,156230,796,723224,535,218237,153,853248,483,724234,724,951295,405,615261,391,952235,637,110246,189,000302,316,148254,982,991271,700,643287,181,007322,722,339310,987,749308,429,548333,822,675287,409,624299,728,123290,267,281219,085,58083,005,72973,139,22951,635,65552,826,40626,606,68026,785,01526,928,16627,684,97124,835,74723,602,85124,673,70925,895,0324,112,9456,457,89312,775,67613,441,16712,490,71012,331,12411,979,39611,034,43411,863,9826,037,7407,253,570
   Common Stock
3,242,963
3,242,963
6,742,963
6,742,963
7,152,713
7,152,713
7,152,713
7,152,713
7,380,698
7,751,765
7,847,676
12,310,488
12,310,488
12,310,488
12,310,488
12,310,488
12,310,488
12,310,488
12,310,488
13,812,023
13,812,023
13,812,023
14,107,881
18,622,881
23,546,500
23,894,710
23,894,710
24,002,295
24,008,795
24,008,795
24,008,795
24,008,795
47,564,021
47,564,021
47,564,021
48,222,609
48,222,609
48,222,609
48,804,207
48,831,044
0
0
0
0
0
0
00000048,831,04448,804,20748,222,60948,222,60948,222,60947,564,02147,564,02147,564,02124,008,79524,008,79524,008,79524,008,79524,002,29523,894,71023,894,71023,546,50018,622,88114,107,88113,812,02313,812,02313,812,02312,310,48812,310,48812,310,48812,310,48812,310,48812,310,48812,310,48812,310,4887,847,6767,751,7657,380,6987,152,7137,152,7137,152,7137,152,7136,742,9636,742,9633,242,9633,242,963
   Retained Earnings 
45,079
152,578
152,578
0
0
184,557
174,779
0
186,042
0
0
0
356,720
0
330,593
0
411,361
104,261
568,169
410,975
436,012
8,609,243
8,652,301
3,716,260
-3,061,649
-7,827,992
-20,089,532
-4,250,327
-29,726,045
-28,139,813
-16,405,223
-60,188,040
-17,942,103
-29,814,908
17,507,122
-46,832,388
2,795,568
9,438,376
20,905,190
-40,697,577
30,197,699
20,336,705
9,164,336
10,430,563
155,524,958
0
0155,524,95810,430,5639,164,33620,336,70530,197,699-40,697,57720,905,1909,438,3762,795,568-46,832,38817,507,122-29,814,908-17,942,103-60,188,040-16,405,223-28,139,813-29,726,045-4,250,327-20,089,532-7,827,992-3,061,6493,716,2608,652,3018,609,243436,012410,975568,169104,261411,3610330,5930356,720000186,0420174,779184,55700152,578152,57845,079
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
282,688,754
284,024,693
284,113,598
285,085,567
285,085,567
284,113,598
223,645,777
223,613,875
223,613,875
230,875,257
170,875,257
189,772,559
208,877,797
209,441,893
0
0
0
0
0
0
000000209,441,893208,877,797189,772,559170,875,257230,875,257223,613,875223,613,875223,645,777284,113,598285,085,567285,085,567284,113,598284,024,693282,688,75400000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
84,077
153,702
1,020
14,193
-283,136
19,175
-4,389,060
-4,400,965
-9,046,707
4,336,892
20,026,655
20,013,841
20,013,841
20,013,841
29,227,295
8,413,589
3,600,644
3,611,772
3,904,164
3,724,318
3,939,049
4,176,311
7,558,364
0
0
0
0
0
0
0000007,558,3644,176,3113,939,0493,724,3183,904,1643,611,7723,600,6448,413,58929,227,29520,013,84120,013,84120,013,84120,026,6554,336,892-9,046,707-4,400,965-4,389,06019,175-283,13614,1931,020153,70284,07700000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue97,990,441
Cost of Revenue-98,739,015
Gross Profit-748,574-748,574
 
Operating Income (+$)
Gross Profit-748,574
Operating Expense-122,505,356
Operating Income-24,514,915-123,253,929
 
Operating Expense (+$)
Research Development5,454,490
Selling General Administrative5,532,760
Selling And Marketing Expenses0
Operating Expense122,505,35610,987,250
 
Net Interest Income (+$)
Interest Income1,288,438
Interest Expense-21,650,382
Other Finance Cost-2,505,561
Net Interest Income-22,867,505
 
Pretax Income (+$)
Operating Income-24,514,915
Net Interest Income-22,867,505
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,503,110-24,514,915
EBIT - interestExpense = -21,650,382
-5,983,400
15,666,982
Interest Expense21,650,382
Earnings Before Interest and Taxes (EBIT)015,147,272
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-6,503,110
Tax Provision--590,063
Net Income From Continuing Ops-5,913,047-5,913,047
Net Income-5,983,400
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net022,867,505
 

Technical Analysis of HLB Life Science Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HLB Life Science Co. Ltd. The general trend of HLB Life Science Co. Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HLB Life Science Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HLB Life Science Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10,800 < 10,810 < 12,080.

The bearish price targets are: 9,150 > 8,000 > 7,700.

Tweet this
HLB Life Science Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HLB Life Science Co. Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HLB Life Science Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HLB Life Science Co. Ltd. The current macd is 218.86.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the HLB Life Science Co. Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for HLB Life Science Co. Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the HLB Life Science Co. Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
HLB Life Science Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHLB Life Science Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HLB Life Science Co. Ltd. The current adx is 32.32.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy HLB Life Science Co. Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
HLB Life Science Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HLB Life Science Co. Ltd. The current sar is 8,296.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
HLB Life Science Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HLB Life Science Co. Ltd. The current rsi is 59.78. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
HLB Life Science Co. Ltd Daily Relative Strength Index (RSI) ChartHLB Life Science Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HLB Life Science Co. Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HLB Life Science Co. Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
HLB Life Science Co. Ltd Daily Stochastic Oscillator ChartHLB Life Science Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HLB Life Science Co. Ltd. The current cci is 122.88.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
HLB Life Science Co. Ltd Daily Commodity Channel Index (CCI) ChartHLB Life Science Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HLB Life Science Co. Ltd. The current cmo is 27.41.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
HLB Life Science Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartHLB Life Science Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HLB Life Science Co. Ltd. The current willr is -16.07142857.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
HLB Life Science Co. Ltd Daily Williams %R ChartHLB Life Science Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HLB Life Science Co. Ltd.

HLB Life Science Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HLB Life Science Co. Ltd. The current atr is 537.73.

HLB Life Science Co. Ltd Daily Average True Range (ATR) ChartHLB Life Science Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HLB Life Science Co. Ltd. The current obv is 128,440,035.

HLB Life Science Co. Ltd Daily On-Balance Volume (OBV) ChartHLB Life Science Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HLB Life Science Co. Ltd. The current mfi is 81.03.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
HLB Life Science Co. Ltd Daily Money Flow Index (MFI) ChartHLB Life Science Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HLB Life Science Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

HLB Life Science Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HLB Life Science Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.779
Ma 20Greater thanMa 509,131.500
Ma 50Greater thanMa 1009,769.200
Ma 100Greater thanMa 20010,387.300
OpenGreater thanClose10,600.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of HLB Life Science Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on HLB Life Science Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HLB Life Science Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HLB Life Science Co. Ltd

I send you an email if I find something interesting about HLB Life Science Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about HLB Life Science Co. Ltd.

Receive notifications about HLB Life Science Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.